Solid Organ Transplant Clinical Trial
Official title:
The Transition From Hospital to Home in Parents of Solid Organ Transplant Recipients
The aim of this study is to determine the influences of discharge teaching and care coordination on how ready a parent is to take their child home from the hospital after a solid organ (kidney, heart and liver) transplant. This study will also look into how the parent handles coping, utilization of healthcare resources, and parent adjustment 3 weeks after discharge from the hospital.
Parents of children that have received a heart, kidney or liver transplant will be asked to
participate in this protocol. Involvement in this study involves completion of
questionnaires prior to the child being discharged from the hospital. Three weeks after
discharge, there will also be a follow-up phone call to complete more questionnaires.
Readiness for hospital discharge is a under-investigated topic in pediatric solid organ
transplant patients, despite the increasing number of pediatric patients undergoing
transplant surgery. Results from this study will be used to develop an intervention program
to promote readiness for hospital discharge in parents of children who receive a solid organ
transplant.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03950414 -
A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients
|
Phase 1 | |
Recruiting |
NCT05663463 -
Seasonal Influenza Vaccine High Dose Boosting in Solid Organ Transplant Recipients
|
N/A | |
Completed |
NCT05124509 -
Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ Transplant
|
||
Completed |
NCT05121142 -
Study of Ruxolitinib for Acute and Chronic Graft Versus Host Disease
|
Phase 1 | |
Completed |
NCT01058239 -
Bortezomib Plus Rituximab for EBV+ PTLD
|
Phase 2 | |
Withdrawn |
NCT03327987 -
Early Flu Shots in SOT
|
||
Completed |
NCT04253548 -
iPeer2Peer Pediatric Thoracic Transplantation
|
N/A | |
Recruiting |
NCT05164016 -
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients
|
||
Withdrawn |
NCT02464306 -
Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection
|
Phase 4 | |
Completed |
NCT02165423 -
Discharge to Home and Chronic Illness Care Pilot
|
N/A | |
Recruiting |
NCT04613206 -
High vs. Standard Dose Influenza Vaccine in Adult SOT Recipients
|
Phase 2 | |
Recruiting |
NCT05550298 -
Multi-Center Molecular Diagnosis and Host Response of Respiratory Viral Infections in Pediatric Transplant Recipients
|
||
Completed |
NCT00518778 -
Fusariosis in Solid-Organ Transplant Recipients
|
N/A | |
Active, not recruiting |
NCT04331275 -
Viral Specific T-cells for Treatment of Viral Infections After Solid Organ Transplant
|
Phase 2 | |
Recruiting |
NCT05968807 -
iParent2Parent Program for Parents of Pediatric Solid Organ Transplant Recipients
|
N/A | |
Active, not recruiting |
NCT03482739 -
Safety, Tolerability and Immunogenicity of a Nine-valent Human Papillomavirus (HPV) Vaccine in HIV and Transplant Patients
|
Phase 3 | |
Not yet recruiting |
NCT04721288 -
REmote moBile Outpatient mOnitoring in Transplant 2.0
|
N/A | |
Completed |
NCT04844489 -
Study of the Humoral Response to SARS-CoV-2 Variants and of the Cellular Response After Vaccination Against COVID-19 in Immunocompromised People
|
N/A | |
Active, not recruiting |
NCT03360682 -
Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV‐1‐Infected Solid Organ Transplant Patients
|
Phase 4 |